2025
Started BlueRidge Life Sciences Pharmaceutical Commercialization Practice
2025
Rebranded as a BlueRidge Life Sciences Company
2024
Acquired Clintrex Research and Suttons Creek
2023
Acquired Modality Solutions
2023
Started HEORStrategies Practice
2023
Started Causation Analysis Practice
2022
ToxStrategies acquired by Renovus Capital Partners
2019
Started EpidStrategies Division
2019
Opened Ashville, North Carolina Office
2018
Started Center of Excellence for 21st Century Toxicology (21CT)
2016
Opened San Francisco Bay Area Office
2012
Opened Tallahassee, Florida Office
2011
Started Pharmaceutical/Biopharmaceutical Practice
2010
Started Food and Consumer Products Practice
2009
Opened the Orange County California Office
2009
Opened the Katy, Texas Office
2008
Mark Harris and Laurie Haws founded ToxStrategies and opened the Austin, Texas Office
